Literature DB >> 22969952

A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer.

Cuimin Ding1, Ruijuan Li, Jingcui Peng, Shengmian Li, Zhanjun Guo.   

Abstract

microRNAs (miRNAs) bind to the 3' untranslated regions (UTRs) of messenger RNAs, where they interfere with translation of genes that regulate cell differentiation, apoptosis and tumourigenesis. The histone methyltransferase SET8 has been reported to methylate TP53 and regulate genomic stability. We analysed a single nucleotide polymorphism (rs16917496) within the miR-502 miRNA seed region at the 3' UTR of SET8 in small-cell lung cancer (SCLC) patients. The SET8 CC+CT genotype was identified to be independently associated with longer survival in SCLC patients by multivariate analysis (relative risk, 0.453; 95% CI 0.217-0.944; p=0.035). The analysis of genetic polymorphisms in miRNA binding sites may help to identify patient subgroups at high risk of poor outcome.

Entities:  

Year:  2012        PMID: 22969952      PMCID: PMC3438626          DOI: 10.3892/etm.2012.469

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  25 in total

1.  MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms.

Authors:  Yan Zeng; Rui Yi; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-05       Impact factor: 11.205

Review 2.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

3.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

4.  An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset.

Authors:  Fengju Song; Hong Zheng; Ben Liu; Sheng Wei; Hongji Dai; Lina Zhang; George A Calin; Xishan Hao; Qingyi Wei; Wei Zhang; Kexin Chen
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

5.  Dynamic regulation of the PR-Set7 histone methyltransferase is required for normal cell cycle progression.

Authors:  Shumin Wu; Weiping Wang; Xiangduo Kong; Lauren M Congdon; Kyoko Yokomori; Marc W Kirschner; Judd C Rice
Journal:  Genes Dev       Date:  2010-10-21       Impact factor: 11.361

6.  Dicer, Drosha, and outcomes in patients with ovarian cancer.

Authors:  William M Merritt; Yvonne G Lin; Liz Y Han; Aparna A Kamat; Whitney A Spannuth; Rosemarie Schmandt; Diana Urbauer; Len A Pennacchio; Jan-Fang Cheng; Alpa M Nick; Michael T Deavers; Alexandra Mourad-Zeidan; Hua Wang; Peter Mueller; Marc E Lenburg; Joe W Gray; Samuel Mok; Michael J Birrer; Gabriel Lopez-Berestein; Robert L Coleman; Menashe Bar-Eli; Anil K Sood
Journal:  N Engl J Med       Date:  2008-12-18       Impact factor: 91.245

7.  Modulation of p53 function by SET8-mediated methylation at lysine 382.

Authors:  Xiaobing Shi; Ioulia Kachirskaia; Hiroshi Yamaguchi; Lisandra E West; Hong Wen; Evelyn W Wang; Sucharita Dutta; Ettore Appella; Or Gozani
Journal:  Mol Cell       Date:  2007-08-17       Impact factor: 17.970

8.  Human polymorphism at microRNAs and microRNA target sites.

Authors:  Matthew A Saunders; Han Liang; Wen-Hsiung Li
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

9.  Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.

Authors:  Debora Landi; Federica Gemignani; Alessio Naccarati; Barbara Pardini; Pavel Vodicka; Ludmila Vodickova; Jan Novotny; Asta Försti; Kari Hemminki; Federico Canzian; Stefano Landi
Journal:  Carcinogenesis       Date:  2008-01-12       Impact factor: 4.944

10.  Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker.

Authors:  Annika Brendle; Haixin Lei; Andreas Brandt; Robert Johansson; Kerstin Enquist; Roger Henriksson; Kari Hemminki; Per Lenner; Asta Försti
Journal:  Carcinogenesis       Date:  2008-06-10       Impact factor: 4.944

View more
  18 in total

1.  Association of functional polymorphism at the miR-502-binding site in the 3' untranslated region of the SETD8 gene with risk of childhood acute lymphoblastic leukemia, a preliminary report.

Authors:  Mohammad Hashemi; Maryam Sheybani-Nasab; Majid Naderi; Fatemeh Roodbari; Mohsen Taheri
Journal:  Tumour Biol       Date:  2014-07-23

2.  The ubiquitin-specific protease USP17 prevents cellular senescence by stabilizing the methyltransferase SET8 and transcriptionally repressing p21.

Authors:  Keishi Fukuura; Yasumichi Inoue; Chiharu Miyajima; Shin Watanabe; Muneshige Tokugawa; Daisuke Morishita; Nobumichi Ohoka; Masayuki Komada; Hidetoshi Hayashi
Journal:  J Biol Chem       Date:  2019-09-18       Impact factor: 5.157

3.  A new layer of degradation mechanism for PR-Set7/Set8 during cell cycle.

Authors:  Nana Zheng; Xiangpeng Dai; Zhiwei Wang; Wenyi Wei
Journal:  Cell Cycle       Date:  2016-09-20       Impact factor: 4.534

4.  A microRNA-related single nucleotide polymorphism of the XPO5 gene is associated with survival of small cell lung cancer patients.

Authors:  Zhanjun Guo; Hongjing Wang; Yantao Li; Bin Li; Cuiqiao Li; Cuimin Ding
Journal:  Biomed Rep       Date:  2013-03-29

Review 5.  MicroRNA binding site polymorphisms as biomarkers in cancer management and research.

Authors:  Monica Cipollini; Stefano Landi; Federica Gemignani
Journal:  Pharmgenomics Pers Med       Date:  2014-07-23

Review 6.  Polymorphisms of microRNA sequences or binding sites and lung cancer: a meta-analysis and systematic review.

Authors:  Zhiwei Chen; Ling Xu; Xiangyun Ye; Shengping Shen; Ziming Li; Xiaomin Niu; Shun Lu
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

Review 7.  The role of microRNAs in cancer susceptibility.

Authors:  Rodolfo Iuliano; Marco Flavio Michele Vismara; Vincenzo Dattilo; Francesco Trapasso; Francesco Baudi; Nicola Perrotti
Journal:  Biomed Res Int       Date:  2013-03-19       Impact factor: 3.411

8.  Genetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese population.

Authors:  Jiali Xu; Zhiqiang Yin; Wen Gao; Lingxiang Liu; Yongmei Yin; Ping Liu; Yongqian Shu
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

9.  SCF(β-TRCP) promotes cell growth by targeting PR-Set7/Set8 for degradation.

Authors:  Zhiwei Wang; Xiangpeng Dai; Jiateng Zhong; Hiroyuki Inuzuka; Lixin Wan; Xiaoning Li; Lixia Wang; Xiantao Ye; Liankun Sun; Daming Gao; Lee Zou; Wenyi Wei
Journal:  Nat Commun       Date:  2015-12-15       Impact factor: 14.919

10.  miR-502 medaited histone methyltransferase SET8 expression is associated with outcome of esophageal squamous cell carcinoma.

Authors:  Cuiju Wang; Jianhua Wu; Yue Zhao; Zhanjun Guo
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.